{
  "name": "Galmed Pharmaceuticals",
  "description": "A biopharmaceutical firm focusing on innovative treatments for liver diseases has filed its annual report and received a new patent for a combination therapy targeting NASH and liver fibrosis.",
  "categoryId": 12,
  "size": "s",
  "logoFile": "logos/galmed_pharmaceuticals-logo.webp",
  "websiteUrl": "https://galmedpharma.com/",
  "careersUrl": null,
  "linkedinId": null,
  "linkedinNum": 895646,
  "crunchbaseId": null,
  "ivcId": "A1000000002327",
  "finderId": "galmed-pharmaceuticals",
  "xId": "GalmedPharma",
  "facebookId": "Galmed-Pharmaceuticals-Ltd-822556341133446",
  "breezyId": null,
  "comeetId": null,
  "greenhouseId": null,
  "leverId": null,
  "addresses": [
    {
      "street": "טיומקין",
      "houseNumber": 16,
      "city": "תל אביב-יפו",
      "lat": 32.0638794,
      "lon": 34.7792602
    }
  ],
  "isMultinational": false,
  "isActive": true
}